PRTN3 and vasculitis: This trend at 6 months became significant in the multivariate analysis after adjusting for PR3-ANCA status, new onset versus relapsing disease status, and baseline Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis (BVAS/WG) score (Table 4).